Advanced Therapy Based Gene and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Advanced Therapy Based on Gene Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Advanced Therapy Based on Gene Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Advanced Therapy Based on Gene Overall Market Size
2.1 Global Advanced Therapy Based on Gene Market Size: 2024 VS 2032
2.2 Global Advanced Therapy Based on Gene Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Advanced Therapy Based on Gene Players in Global Market
3.2 Top Global Advanced Therapy Based on Gene Companies Ranked by Revenue
3.3 Global Advanced Therapy Based on Gene Revenue by Companies
3.4 Top 3 and Top 5 Advanced Therapy Based on Gene Companies in Global Market, by Revenue in 2024
3.5 Global Companies Advanced Therapy Based on Gene Product Type
3.6 Tier 1, Tier 2, and Tier 3 Advanced Therapy Based on Gene Players in Global Market
3.6.1 List of Global Tier 1 Advanced Therapy Based on Gene Companies
3.6.2 List of Global Tier 2 and Tier 3 Advanced Therapy Based on Gene Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Advanced Therapy Based on Gene Market Size Markets, 2024 & 2032
4.1.2 Viral
4.1.3 Non-viral
4.2 Segmentation by Type - Global Advanced Therapy Based on Gene Revenue & Forecasts
4.2.1 Segmentation by Type - Global Advanced Therapy Based on Gene Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Advanced Therapy Based on Gene Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Advanced Therapy Based on Gene Market Size, 2024 & 2032
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 Other
5.2 Segmentation by Application - Global Advanced Therapy Based on Gene Revenue & Forecasts
5.2.1 Segmentation by Application - Global Advanced Therapy Based on Gene Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Advanced Therapy Based on Gene Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Advanced Therapy Based on Gene Market Size, 2024 & 2032
6.2 By Region - Global Advanced Therapy Based on Gene Revenue & Forecasts
6.2.1 By Region - Global Advanced Therapy Based on Gene Revenue, 2020-2025
6.2.2 By Region - Global Advanced Therapy Based on Gene Revenue, 2026-2032
6.2.3 By Region - Global Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Advanced Therapy Based on Gene Revenue, 2020-2032
6.3.2 United States Advanced Therapy Based on Gene Market Size, 2020-2032
6.3.3 Canada Advanced Therapy Based on Gene Market Size, 2020-2032
6.3.4 Mexico Advanced Therapy Based on Gene Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Advanced Therapy Based on Gene Revenue, 2020-2032
6.4.2 Germany Advanced Therapy Based on Gene Market Size, 2020-2032
6.4.3 France Advanced Therapy Based on Gene Market Size, 2020-2032
6.4.4 U.K. Advanced Therapy Based on Gene Market Size, 2020-2032
6.4.5 Italy Advanced Therapy Based on Gene Market Size, 2020-2032
6.4.6 Russia Advanced Therapy Based on Gene Market Size, 2020-2032
6.4.7 Nordic Countries Advanced Therapy Based on Gene Market Size, 2020-2032
6.4.8 Benelux Advanced Therapy Based on Gene Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Advanced Therapy Based on Gene Revenue, 2020-2032
6.5.2 China Advanced Therapy Based on Gene Market Size, 2020-2032
6.5.3 Japan Advanced Therapy Based on Gene Market Size, 2020-2032
6.5.4 South Korea Advanced Therapy Based on Gene Market Size, 2020-2032
6.5.5 Southeast Asia Advanced Therapy Based on Gene Market Size, 2020-2032
6.5.6 India Advanced Therapy Based on Gene Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Advanced Therapy Based on Gene Revenue, 2020-2032
6.6.2 Brazil Advanced Therapy Based on Gene Market Size, 2020-2032
6.6.3 Argentina Advanced Therapy Based on Gene Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Advanced Therapy Based on Gene Revenue, 2020-2032
6.7.2 Turkey Advanced Therapy Based on Gene Market Size, 2020-2032
6.7.3 Israel Advanced Therapy Based on Gene Market Size, 2020-2032
6.7.4 Saudi Arabia Advanced Therapy Based on Gene Market Size, 2020-2032
6.7.5 UAE Advanced Therapy Based on Gene Market Size, 2020-2032
7 Companies Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Advanced Therapy Based on Gene Major Product Offerings
7.1.4 Biogen Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.1.5 Biogen Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Advanced Therapy Based on Gene Major Product Offerings
7.2.4 Novartis Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.2.5 Novartis Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Advanced Therapy Based on Gene Major Product Offerings
7.3.4 Gilead Sciences Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Corporate Summary
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Advanced Therapy Based on Gene Major Product Offerings
7.4.4 Sarepta Therapeutics Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.4.5 Sarepta Therapeutics Key News & Latest Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.5.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Advanced Therapy Based on Gene Major Product Offerings
7.6.4 Amgen Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.6.5 Amgen Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Corporate Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Advanced Therapy Based on Gene Major Product Offerings
7.7.4 Spark Therapeutics Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Advanced Therapy Based on Gene Major Product Offerings
7.8.4 Akcea Therapeutics Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.8.5 Akcea Therapeutics Key News & Latest Developments
7.9 Sunway Biotech
7.9.1 Sunway Biotech Corporate Summary
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Advanced Therapy Based on Gene Major Product Offerings
7.9.4 Sunway Biotech Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.9.5 Sunway Biotech Key News & Latest Developments
7.10 SIBIONO
7.10.1 SIBIONO Corporate Summary
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Advanced Therapy Based on Gene Major Product Offerings
7.10.4 SIBIONO Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.10.5 SIBIONO Key News & Latest Developments
7.11 AnGes
7.11.1 AnGes Corporate Summary
7.11.2 AnGes Business Overview
7.11.3 AnGes Advanced Therapy Based on Gene Major Product Offerings
7.11.4 AnGes Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.11.5 AnGes Key News & Latest Developments
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Corporate Summary
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Advanced Therapy Based on Gene Major Product Offerings
7.12.4 Orchard Therapeutics Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.12.5 Orchard Therapeutics Key News & Latest Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Corporate Summary
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Advanced Therapy Based on Gene Major Product Offerings
7.13.4 Human Stem Cells Institute Advanced Therapy Based on Gene Revenue in Global Market (2020-2025)
7.13.5 Human Stem Cells Institute Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Advanced Therapy Based on Gene Market Opportunities & Trends in Global Market
Table 2. Advanced Therapy Based on Gene Market Drivers in Global Market
Table 3. Advanced Therapy Based on Gene Market Restraints in Global Market
Table 4. Key Players of Advanced Therapy Based on Gene in Global Market
Table 5. Top Advanced Therapy Based on Gene Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Advanced Therapy Based on Gene Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Advanced Therapy Based on Gene Revenue Share by Companies, 2020-2025
Table 8. Global Companies Advanced Therapy Based on Gene Product Type
Table 9. List of Global Tier 1 Advanced Therapy Based on Gene Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Advanced Therapy Based on Gene Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Advanced Therapy Based on Gene Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Advanced Therapy Based on Gene Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Advanced Therapy Based on Gene Revenue, (US$, Mn), 2026-2032
Table 30. Biogen Corporate Summary
Table 31. Biogen Advanced Therapy Based on Gene Product Offerings
Table 32. Biogen Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 33. Biogen Key News & Latest Developments
Table 34. Novartis Corporate Summary
Table 35. Novartis Advanced Therapy Based on Gene Product Offerings
Table 36. Novartis Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 37. Novartis Key News & Latest Developments
Table 38. Gilead Sciences Corporate Summary
Table 39. Gilead Sciences Advanced Therapy Based on Gene Product Offerings
Table 40. Gilead Sciences Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Sarepta Therapeutics Corporate Summary
Table 43. Sarepta Therapeutics Advanced Therapy Based on Gene Product Offerings
Table 44. Sarepta Therapeutics Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 45. Sarepta Therapeutics Key News & Latest Developments
Table 46. Alnylam Pharmaceuticals Corporate Summary
Table 47. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Offerings
Table 48. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 49. Alnylam Pharmaceuticals Key News & Latest Developments
Table 50. Amgen Corporate Summary
Table 51. Amgen Advanced Therapy Based on Gene Product Offerings
Table 52. Amgen Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 53. Amgen Key News & Latest Developments
Table 54. Spark Therapeutics Corporate Summary
Table 55. Spark Therapeutics Advanced Therapy Based on Gene Product Offerings
Table 56. Spark Therapeutics Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 57. Spark Therapeutics Key News & Latest Developments
Table 58. Akcea Therapeutics Corporate Summary
Table 59. Akcea Therapeutics Advanced Therapy Based on Gene Product Offerings
Table 60. Akcea Therapeutics Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 61. Akcea Therapeutics Key News & Latest Developments
Table 62. Sunway Biotech Corporate Summary
Table 63. Sunway Biotech Advanced Therapy Based on Gene Product Offerings
Table 64. Sunway Biotech Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 65. Sunway Biotech Key News & Latest Developments
Table 66. SIBIONO Corporate Summary
Table 67. SIBIONO Advanced Therapy Based on Gene Product Offerings
Table 68. SIBIONO Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 69. SIBIONO Key News & Latest Developments
Table 70. AnGes Corporate Summary
Table 71. AnGes Advanced Therapy Based on Gene Product Offerings
Table 72. AnGes Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 73. AnGes Key News & Latest Developments
Table 74. Orchard Therapeutics Corporate Summary
Table 75. Orchard Therapeutics Advanced Therapy Based on Gene Product Offerings
Table 76. Orchard Therapeutics Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 77. Orchard Therapeutics Key News & Latest Developments
Table 78. Human Stem Cells Institute Corporate Summary
Table 79. Human Stem Cells Institute Advanced Therapy Based on Gene Product Offerings
Table 80. Human Stem Cells Institute Advanced Therapy Based on Gene Revenue (US$, Mn) & (2020-2025)
Table 81. Human Stem Cells Institute Key News & Latest Developments
List of Figures
Figure 1. Advanced Therapy Based on Gene Product Picture
Figure 2. Advanced Therapy Based on Gene Segment by Type in 2024
Figure 3. Advanced Therapy Based on Gene Segment by Application in 2024
Figure 4. Global Advanced Therapy Based on Gene Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Advanced Therapy Based on Gene Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Advanced Therapy Based on Gene Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Advanced Therapy Based on Gene Revenue in 2024
Figure 9. Segmentation by Type � Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Advanced Therapy Based on Gene Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 13. By Region - Global Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 14. By Country - North America Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 15. United States Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 19. Germany Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 20. France Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 27. China Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 31. India Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 33. Brazil Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Advanced Therapy Based on Gene Revenue Market Share, 2020-2032
Figure 36. Turkey Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Advanced Therapy Based on Gene Revenue, (US$, Mn), 2020-2032
Figure 40. Biogen Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Novartis Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Gilead Sciences Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Sarepta Therapeutics Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Amgen Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Spark Therapeutics Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Akcea Therapeutics Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Sunway Biotech Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. SIBIONO Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. AnGes Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Orchard Therapeutics Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Human Stem Cells Institute Advanced Therapy Based on Gene Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Industry Market Size
